Migraine and hypertension

Neurological Sciences

Volumn 29, Issue SUPPL. 1, 2008, Pages

  Agostoni, Elio ^a   Aliprandi, Angelo ^a  

^a A MANZONI HOSPITAL   (Italy)

Author keywords

Comorbidity Cardiovascular risk factors; Hypertension; Migraine

Indexed keywords

ANGIOTENSIN; CALCITONIN GENE RELATED PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OLMESARTAN; SEROTONIN;

ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; GENE MUTATION; HUMAN; HYPERTENSION; MIGRAINE; NONHUMAN; PATHOPHYSIOLOGY; PROPHYLAXIS; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SEROTONIN RELEASE; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; HUMANS; HYPERTENSION; MIGRAINE DISORDERS; RISK FACTORS;

EID: 45249119970     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-008-0883-8     Document Type: Article

References (27)

1. Moskowitz MA (2007) Pathophysiology of headache - past and present. Headache 47[Suppl 1]:S58-S63
2. Merikangas KR, Fenton BT (1994) Comorbidity of migraine with somatic disorders in a large-scale epidemiologic study in the United States. In: Olesen J (ed) Headache classification and epidemiology. Raven, New York, pp 301-314
3. Franceschi M, Colombo B, Rossi P, Canal N (1997) Headache in a population-based elderly cohort. An ancillary study to the Italian Longitudinal Study of Aging (ILSA). Headache 37:79-82
4. Cirillo M, Stellato D, Lombardi C et al (1999) Headache and cardiovascular risk factors: Positive association with hypertension. Headache 39:409-416
5. Markush RE, Karp HR, Heyman A, O'Fallon WM (1975) Epidemiologic study of migraine symptoms in young women. Neurology 25:430-435
6. Marcoux S, Berube S, Brisson J, Fabia J (1992) History of migraine and risk of pregnancy-induced hypertension. Epidemiology 3:53-56
7. Waters WE (1971) Headache and blood pressure in the community. BMJ 1:142-143
8. Chen TC, Leviton A, Edelstein S, Ellenberg JH (1987) Migraine and other diseases in women of reproductive age. The influence of smoking on observed associations. Arch Neurol 44:1024-1028
9. Rasmussen BK, Olesen J (1992) Symptomatic and nonsymptomatic headaches in a general population. Neurology 42:1225-1231
10. Wiehe M, Fuchs SC, Moreira LB et al (2002) Migraine is more frequent in individuals with optimal and normal blood pressure: A population-based study. J Hypertens 20:1303-1306
11. Tzourio C, Gagniere B, El Amrani M et al (2003) Relationship between migraine, blood pressure and carotid thickness. A population-based study in the elderly. Cephalalgia 23:914-920
12. Pietrini U, De Luca M, De Santis G (2005) Hypertension in headache patients? A clinical study. Acta Neurol Scand 112:259-264
13. Gudmundsson LS, Thorgeirsson G, Sigfusson N et al (2005) Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21 537 subjects. The Reykjavik Study. Cephalalgia 26:436-444
14. Gretchen E, Tietjen MD, Nabeel A et al (2007) Migraine comorbidity constellations. Headache 47:857-865
15. Scher AI, Terwindt GM, Picavet HS et al (2005) Cardiovascular risk factors and migraine: The GEM populationbased study. Neurology 64:614-620
16. Kurth T, Gaziano JM, Cook NR et al (2006) Migraine and risk of cardiovascular disease in women. JAMA 296:283-291
17. Charles JA, Jotkowitz S, Byrd LH (2006) Prevention of migraine with olmesartan in patients with hypertension/prehypertension. Headache 46:503-507
18. Tronvik E, Stovner LJ, Helde G et al (2003) Prophylactic treatment of migraine with an angiotensin II receptor blocker. JAMA 289:65-69
19. Allen AM, Moeller I, Jenkins TA et al (1998) Angiotensin receptors in the nervous system. Brain Res Bull 47:17-28
20. Mendelsohn FA, Jenkins TA, Berkovic SF (1993) Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res 613:221-229
21. Baltatu O, Afeche SC, Jose dos Santos SH et al (2002) Locally synthesized angiotensin modulates pineal melatonin generation. J Neurochem 80:328-334
22. Reuter U, Chiarugi A, Bolay H, Moskowitz MA (2002) Nuclear factor-kappa B as a molecular target for migraine therapy. Ann Neurol 51:507-516
23. Lorenzo O, Ruiz-Ortega M, Suzuki Y et al (2002) Angiotensin III activates nuclear transcription factorkappa B in cultured mesangial cells via AT2 receptors. J Am Soc Nephrol 13:1162-1171
24. Paterna S, DiPasquale P, D'Angelo A et al (2000) Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 43:133-136
25. Juhasz G, Zsombok T, Modos EA et al (2003) NO-induced migraine attack: strong increase in plasma calcitonin generelated peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461-470
26. Franco-Cereceda A, Gennari C, Nami R et al (1987) Cardiovascular effects of calcitonin gene-related peptides I and II in man. Circ Res 60:393-397
27. Juhasz G, Zsombok T, Laszik A et al (2003) Despite the general correlation of the serotonin transporter gene regulatory region polymorphism (5-HTTLPR) and platelet serotonin concentration, lower platelet serotonin concentration in migraine patients is independent of the 5-HTTLPR variants. Neurosci Lett 350:56-60